Keywords: Bulgaria, Pharmaceutical market, Regulatory environment, Corruption, Generic penetration

Bulgaria Pharmaceuticals market among less attractive and corruption remains a problem, says BMI

Article | 20 September 2010

Bulgaria as one of the less attractive pharmaceutical markets in the Emerging Europe region, says market research group Business Monitor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in